Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8)

Arnon Nagler; Christophe Peczynski; Bhagirathbhai Dholaria; Myriam Labopin; Thomas Valerius; Peter Dreger; Nicolaus Kröger; Hans Christian Reinhardt; Jürgen Finke; Georg Nikolaus Franke; Fabio Ciceri; Mareike Verbeek; Igor Wolfgang Blau; Martin Bornhäuser; Alexandros Spyridonidis; Gesine Bug; Ali Bazarbachi; Christophe Schmid; Ibrahim Yakoub-Agha; Bipin N. Savani; Mohamad Mohty

doi:10.1038/s41409-022-01834-z

Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8)

Arnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria^*, Myriam Labopin, Thomas Valerius, Peter Dreger, Nicolaus Kröger, Hans Christian Reinhardt, Jürgen Finke, Georg Nikolaus Franke, Fabio Ciceri, Mareike Verbeek, Igor Wolfgang Blau, Martin Bornhäuser, Alexandros Spyridonidis, Gesine Bug, Ali Bazarbachi, Christophe Schmid, Ibrahim Yakoub-Agha, Bipin N. SavaniMohamad Mohty

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Abstract

The caption of Fig. 1 was corrected from “Transplant outcomes. Non-relapse mortality (a, NRM), relapse incidence (b, RI), leukemiafree survival (c, LFS), and overall survival(d, OS) patients receiving post-transplant cyclophosphamide (PTCy) versus Cyclosporine A (CSA) / methotrexate (MTX)” to “Transplant outcomes. Non-relapse mortality (a, NRM), relapse incidence (b, RI), leukemia-free survival(c, LFS), and overall survival (d, OS) of patients receiving reduced intensity versus myeloablative conditioning regimen”. The original article has been corrected.

Original language	English
Pages (from-to)	1854
Number of pages	1
Journal	Bone Marrow Transplantation
Volume	57
Issue number	12
DOIs	https://doi.org/10.1038/s41409-022-01834-z
State	Published - Dec 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41409-022-01834-z

Fingerprint

Dive into the research topics of 'Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8)'. Together they form a unique fingerprint.

Cite this

Nagler, A., Peczynski, C., Dholaria, B., Labopin, M., Valerius, T., Dreger, P., Kröger, N., Reinhardt, H. C., Finke, J., Franke, G. N., Ciceri, F., Verbeek, M., Blau, I. W., Bornhäuser, M., Spyridonidis, A., Bug, G., Bazarbachi, A., Schmid, C., Yakoub-Agha, I., ... Mohty, M. (2022). Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8). Bone Marrow Transplantation, 57(12), 1854. https://doi.org/10.1038/s41409-022-01834-z

Nagler, Arnon ; Peczynski, Christophe ; Dholaria, Bhagirathbhai et al. / Correction to : Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8). In: Bone Marrow Transplantation. 2022 ; Vol. 57, No. 12. pp. 1854.

@article{25b341a4ad31402f8434cf8fee9b0f53,

title = "Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8)",

abstract = "The caption of Fig. 1 was corrected from “Transplant outcomes. Non-relapse mortality (a, NRM), relapse incidence (b, RI), leukemiafree survival (c, LFS), and overall survival(d, OS) patients receiving post-transplant cyclophosphamide (PTCy) versus Cyclosporine A (CSA) / methotrexate (MTX)” to “Transplant outcomes. Non-relapse mortality (a, NRM), relapse incidence (b, RI), leukemia-free survival(c, LFS), and overall survival (d, OS) of patients receiving reduced intensity versus myeloablative conditioning regimen”. The original article has been corrected.",

author = "Arnon Nagler and Christophe Peczynski and Bhagirathbhai Dholaria and Myriam Labopin and Thomas Valerius and Peter Dreger and Nicolaus Kr{\"o}ger and Reinhardt, {Hans Christian} and J{\"u}rgen Finke and Franke, {Georg Nikolaus} and Fabio Ciceri and Mareike Verbeek and Blau, {Igor Wolfgang} and Martin Bornh{\"a}user and Alexandros Spyridonidis and Gesine Bug and Ali Bazarbachi and Christophe Schmid and Ibrahim Yakoub-Agha and Savani, {Bipin N.} and Mohamad Mohty",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature Limited 2022.",

year = "2022",

month = dec,

doi = "10.1038/s41409-022-01834-z",

language = "אנגלית",

volume = "57",

pages = "1854",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "12",

}

Nagler, A, Peczynski, C, Dholaria, B, Labopin, M, Valerius, T, Dreger, P, Kröger, N, Reinhardt, HC, Finke, J, Franke, GN, Ciceri, F, Verbeek, M, Blau, IW, Bornhäuser, M, Spyridonidis, A, Bug, G, Bazarbachi, A, Schmid, C, Yakoub-Agha, I, Savani, BN & Mohty, M 2022, 'Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8)', Bone Marrow Transplantation, vol. 57, no. 12, pp. 1854. https://doi.org/10.1038/s41409-022-01834-z

Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8). / Nagler, Arnon; Peczynski, Christophe; Dholaria, Bhagirathbhai et al.
In: Bone Marrow Transplantation, Vol. 57, No. 12, 12.2022, p. 1854.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8)

AU - Nagler, Arnon

AU - Peczynski, Christophe

AU - Dholaria, Bhagirathbhai

AU - Labopin, Myriam

AU - Valerius, Thomas

AU - Dreger, Peter

AU - Kröger, Nicolaus

AU - Reinhardt, Hans Christian

AU - Finke, Jürgen

AU - Franke, Georg Nikolaus

AU - Ciceri, Fabio

AU - Verbeek, Mareike

AU - Blau, Igor Wolfgang

AU - Bornhäuser, Martin

AU - Spyridonidis, Alexandros

AU - Bug, Gesine

AU - Bazarbachi, Ali

AU - Schmid, Christophe

AU - Yakoub-Agha, Ibrahim

AU - Savani, Bipin N.

AU - Mohty, Mohamad

PY - 2022/12

Y1 - 2022/12

N2 - The caption of Fig. 1 was corrected from “Transplant outcomes. Non-relapse mortality (a, NRM), relapse incidence (b, RI), leukemiafree survival (c, LFS), and overall survival(d, OS) patients receiving post-transplant cyclophosphamide (PTCy) versus Cyclosporine A (CSA) / methotrexate (MTX)” to “Transplant outcomes. Non-relapse mortality (a, NRM), relapse incidence (b, RI), leukemia-free survival(c, LFS), and overall survival (d, OS) of patients receiving reduced intensity versus myeloablative conditioning regimen”. The original article has been corrected.

AB - The caption of Fig. 1 was corrected from “Transplant outcomes. Non-relapse mortality (a, NRM), relapse incidence (b, RI), leukemiafree survival (c, LFS), and overall survival(d, OS) patients receiving post-transplant cyclophosphamide (PTCy) versus Cyclosporine A (CSA) / methotrexate (MTX)” to “Transplant outcomes. Non-relapse mortality (a, NRM), relapse incidence (b, RI), leukemia-free survival(c, LFS), and overall survival (d, OS) of patients receiving reduced intensity versus myeloablative conditioning regimen”. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85139484727&partnerID=8YFLogxK

U2 - 10.1038/s41409-022-01834-z

DO - 10.1038/s41409-022-01834-z

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 36207624

AN - SCOPUS:85139484727

SN - 0268-3369

VL - 57

SP - 1854

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 12

ER -

Nagler A, Peczynski C, Dholaria B, Labopin M, Valerius T, Dreger P et al. Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8). Bone Marrow Transplantation. 2022 Dec;57(12):1854. doi: 10.1038/s41409-022-01834-z

Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this